Adaptive Biotechnologies Corp’s recent filing unveils that its Chief Financial Officer PISKEL KYLE unloaded Company’s shares for reported $1235.0 on Nov 18 ’24. In the deal valued at $4.98 per share,248 shares were sold. As a result of this transaction, PISKEL KYLE now holds 154,330 shares worth roughly $1.1 million.
Then, Taylor Stacy L sold 26,922 shares, generating $121,079 in total proceeds. Upon selling the shares at $4.50, the SVP and General Counsel now owns 139,365 shares.
Before that, STACY L TAYLOR bought 26,922 shares. Adaptive Biotechnologies Corp shares valued at $121,079 were divested by the Officer at a price of $4.50 per share.
A number of analysts have revised their coverage, including Scotiabank’s analysts, who began to cover the stock in early January with a ‘”a Sector outperform”‘ rating. Piper Sandler also remained covering ADPT and has increased its forecast on December 21, 2022 with a “an Overweight” recommendation from previously “Neutral” rating. Credit Suisse started covering the stock on August 25, 2022. It rated ADPT as “an Underperform”.
Price Performance Review of ADPT
On Tuesday, Adaptive Biotechnologies Corp [NASDAQ:ADPT] saw its stock jump 0.71% to $7.10. Over the last five days, the stock has gained 16.20%. Adaptive Biotechnologies Corp shares have risen nearly 18.43% since the year began. Nevertheless, the stocks have risen 55.02% over the past one year. While a 52-week high of $7.46 was reached on 01/06/25, a 52-week low of $2.28 was recorded on 01/02/25. SMA at 50 days reached $5.83, while 200 days put it at $4.37.
Levels Of Support And Resistance For ADPT Stock
The 24-hour chart illustrates a support level at 6.70, which if violated will result in even more drops to 6.30. On the upside, there is a resistance level at 7.47. A further resistance level may holdings at 7.83. The Relative Strength Index (RSI) on the 14-day chart is 62.94, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.69, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 21.75%. Stochastics %K at 84.02% indicates the stock is a selling.
How much short interest is there in Adaptive Biotechnologies Corp?
A steep rise in short interest was recorded in Adaptive Biotechnologies Corp stocks on 2024-12-13, growing by 0.83 million shares to a total of 9.03 million shares. Yahoo Finance data shows the prior-month short interest on 2024-11-15 was 8.2 million shares. There was a rise of 9.15%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on June 03, 2022 when Piper Sandler began covering the stock and recommended ‘”a Neutral”‘ rating along with a $7.50 price target.
